Indications and uses
relieves travelers’ diarrhea diarrhea upset stomach due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching
relieves travelers’ diarrhea diarrhea upset stomach due to overindulgence in food and drink, including: heartburn indigestion nausea gas belching
shake well before use for accurate dosing, use dose cup adults and children 12 years and over: 1 dose (30 mL) every 1/2 to 1 hour as needed do not exceed 8 doses (240 mL) in 24 hours use until diarrhea stops but not more than 2 days children under 12 years: ask a doctor drink plenty of clear fluids to help prevent dehydration caused by diarrhea
each 30 mL contains: sodium 10 mg salicylate 261 mg low sodium sugar free store at room temperature protect from freezing avoid excessive heat (more than over 104°F or 40°C).
Bismuth subsalicylate 525 mg
Upset stomach reliever and antidiarrheal
relieves
Reye’s syndrome:Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.
Allergy alert: Contains salicylate. Do not take if you are
if you have
taking any drug for
a temporary, but harmless, darkening of the stool and/or tongue may occur
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
carboxymethylcellulose sodium, D&C red #22, D&C red #28, flavor, microcrystalline cellulose, potassium hydroxide, potassium sorbate, purified water, salicylic acid, Simethicone emulsion, sodium benzoate, sucralose, xanthan gum
Call 1-800-910-6874
Safety Sealed: DO NOT USE IF IMPRINTED SHRINK BAND IS MISSING OR BROKEN
NDC 11673-706-08
Compare to active ingredient in Pepto-Bismol® Regular Strength*
5-symptom
digestive relief
bismuth subsalicylate 525 mg
upset stomach reliever/antidiarrheal
relieves nausea, heartburn, indigestion, upset stomach and diarrhea
8 FL OZ (236 mL)
Dist. By Target Corp, Mpls , MN 55403
*This product is not manufactured or distributed by Procter & Gamble, distributor of Pepto-Bismol ®Regular Strength.

| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 308762 | bismuth subsalicylate 525 MG in 30 mL Oral Suspension | PSN | 7 |
| 308762 | bismuth subsalicylate 17.5 MG/ML Oral Suspension | SCD | 7 |
| 308762 | bismuth subsalicylate 1.75 % Oral Suspension | SY | 7 |
| 308762 | bismuth subsalicylate 262 MG per 15 ML Oral Suspension | SY | 7 |
| 308762 | bismuth subsalicylate 524 MG per 30 ML Oral Suspension | SY | 7 |
| 308762 | bismuth subsalicylate 525 MG per 30 ML Oral Suspension | SY | 7 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15 | Product name | 1 | 20240313 |
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-706-08 | up and up digestive relief | 236 mL in 1 BOTTLE | SUSPENSION | 236 | 7 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11673-706 | 11673-706-08 |
Every source-derived ingredient row is available through these pages.
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 6 | 2024-11-07 | full-release | 2026-06-01 00:35:36 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| up and up digestive relief | BISMUTH SUBSALICYLATE | Target Corporation | 5731025d-ffaa-4b31-971f-e58b921e40ed | 2025-11-05 | Warnings | 11673-706-08 11673-706 11673070608 42d66c91-c31d-408c-e063-6294a90a9ca9 5731025d-ffaa-4b31-971f-e58b921e40ed |
Adverse event summaries are temporarily unavailable. Other product information remains available.